Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1
Description
COVID-19 results from SARS-CoV-2, which mutates frequently, challenging current treatments. Therefore, it is critical to develop new therapeutic drugs against this disease. This study explores the interaction between SARS-CoV-2 3CL^(pro) and
